- Business Type:
-
Manufacturer
- Year Established:
-
2005
- Total Revenue:
-
US$50 Million - US$100 Million
- Main Products:
-
Pharmaceutical Raw Material, Pharmaceutical Intermediate, Sitagliptin phosphate,<br /> Vildagliptin, Tapentadol, Raltegravir, Bendamustine HCL, Ivabradine HCL
Product Showcase
-
Sitagliptin Phosphate
-
(2S)-1-(Chloroacetyl)-2-Pyrrolidine Carbonitrile
-
3-Amino-1-hydroxyadamantane
-
1-Methyl-5-Amino-1H-Benzimidazole-2-Butanoic Acid Ethyl Ester
-
16,17-Dihydroxyviolanthrone
-
2-Methyl-1-nitronaphthalene
View All Products